Their technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients (APIs), fine chemicals, agrochemicals, food ingredients, and detergents. They also enable rapid transfer to commercial manufacturing scale.
Codexis offers enzyme optimization and supply, from small scale through to commercial quantities. They have developed – and produced – enzymes for more than 10 commercial processes.
Their proprietary and cutting-edge CodeEvolver® directed evolution technology platform allows rapid development of highly optimized enzymes that are used in new, highly efficient and environmentally friendly biocatalytic manufacturing processes. In fact, thier infrastructure is such that it allows scale up of optimized enzymes in a matter of weeks and full commercial production in three months.
Codexis expertise in directed evolution, guided by proprietary software and bioinformatic systems, including our Mosaic™ and Sage™ directed evolution technology platforms, has resulted in the creation of ready-to-access biocatalyst libraries of enzymes with enhanced properties and features.
Their off-the-shelf Codex® screening kits and panels enable their customers to quickly assess the feasibility of a biocatalytic approach to a product of interest, and provide the basis for further optimization, if required.
How do you find